Diagnostic und Therapeutic Value of Cell-free Circulating DNA as a Non-invasive Biomarker in Patients with Prostate Cancer

Author(s): Stefan Latz, Stefan C. Muller, Jorg Ellinger.

Journal Name:Current Cancer Therapy Reviews

Volume 9 , Issue 4 , 2013


The presence of small amounts of circulating DNA in plasma was demonstrated 60 years ago. Since then, cellfree DNA has been tested for quantity, fragmentation pattern and tumor-specific sequences in patients with various malignancies. The introduction of improved detection methods showed that all these alterations are regularly detectable in many cancer patients and the investigation of cell-free DNA may provide useful diagnostic and prognostic information. Herein, we review the recent findings on cell-free DNA alterations in patients with prostate cancer and discuss its diagnostic and prognostic potential.

Keywords: Prostate cancer, DNA fragmentation, cell-free DNA, DNA methylation, allelic imbalance.

Rights & PermissionsPrintExport

Article Details

Year: 2013
Page: [258 - 264]
Pages: 7
DOI: 10.2174/157339470904140418094329
Price: $58